Endometriomas Clinical Trial
Official title:
Anti-mullerian Hormone in Ovarian Reserve Evaluation After Treatment of Endometriomas With Alcohol Sclerotherapy Versus Surgery. A Pilot Study.
The purpose of this multicenter study is to evaluate the ovarian reserve after alcohol sclerotherapy of endometriomas versus conventional surgery.
Between 5-10% fertile women are affected by endometriosis, and ovarian endometrioma is
present in 17-44% of cases, with 40% of patients with endometriomas being sterile. However,
the "gold standard" treatment is laparoscopic ovarian cystectomy and this therapy is
associated with a diminished ovarian reserve, with a significant antimullerian hormone (AMH)
decrease.
Alcohol sclerotherapy is a new minimal invasive procedure in endometrioma treatment whose
potential beneficial effect in fertility preservation is not still demonstrated.
The investigators would like to demonstrate that this procedure improves fertility
preservation and reduces morbidity and costs in contrast with conventional surgery.
Moreover,the investigators would like to demonstrate that this procedure could be performed
in different centers with similar results.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06426420 -
Endometriosis and ATR-FTIR Spectroscopy
|
N/A |